Michael Kane

Michael Kane currently holds the position of Associate Professor at MD Anderson Cancer Center since June 2024 and serves as an Adjunct Assistant Professor at Yale University since June 2016. Additionally, Michael has been the Director of the Biostatistics Data Science Pathway at Yale. As a co-founder and Scientific Advisor for Telperian Inc since May 2018, Michael continues in this role after the company's rebranding from Presagia Inc in December 2023. Previous roles include serving as a Statistical Expert in Residence at IGNYTA, Inc. and as an Associate Research Scientist at Yale University from September 2010 to June 2015. Michael earned a Master of Science in Electrical Engineering from the Rochester Institute of Technology and completed undergraduate studies at Ohio University.